| 0.56 | 1.43% |
| SLXP NASDAQSalix Pharmaceuticals Ltd. | |
Market Cap 2.293B Book Value 6.472 EBITDA -12.0M PEG Ratio 29.94 EPS -1.178 P/B Ratio 6.04 Short Ratio 6.50 Index Membership S&P Sector Healthcare Full Time Employees 395 Profile Get Profile for: Drug Related Products Open 39.06 High 39.75 Low 38.98 Volume 199.4 K Target Price 50.60 Current EPS -1.178 This Year EPS 0.03 Next Year EPS 1.55 This Year PE 1303.33 Next Year PE 25.23 | Symbol | SLXP | | Name | Salix Pharmaceuticals Ltd. | | Type | Stock | | Country | United States | | Exchange | NASDAQ |
| | Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. |
Company Summary more  Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, Salix has products under development for the treatment of hepatic encephalopathy and irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars?Sinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina. Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Top Stories| | 2010-08-31 |  | |
| | |
Earnings Postmortem for NBTY; NTY, PRGO, SLXP, HLF
Learning Markets - Aug 31, 2010
NBTY, Inc. (NTY) [Chart - Analysis - News] released its most recent earnings statement about a month ago on Wednesday, July 28th. NBTY, Inc. beat expectations with a profit of $1.03 per share---21 ...
2010-08-31 |  | |
| | | 2010-08-30 |  | |
| | | 2010-08-30 |  | |
|
| | A rally among airlines and a surprise jump in factory orders pushed US stocks higher in choppy trading on Tuesday. 2010-09-02 |  | |
|
Community Discussions | | | (0.04) | 0.07% |
| NTY NYSENBTY Inc. | |
Market Cap 3.455B Book Value 20.709 EBITDA 480.6M PEG Ratio 1.61 EPS 3.935 P/E 13.86 P/B Ratio 2.63 Short Ratio 0.10 Index Membership S&P Sector Healthcare Full Time Employees 13,950 Profile Get Profile for: Drug Related Products Open 54.46 High 54.51 Low 54.44 Volume 1.3 M Target Price 52.14 Current EPS 3.935 This Year EPS 3.75 Next Year EPS 3.89 Current PE 13.86 This Year PE 14.54 Next Year PE 14.02 | Symbol | NTY | | Name | NBTY Inc. | | Type | Stock | | Country | United States | | Exchange | NYSE |
| | NBTY, Inc. manufactures, markets, and retails nutritional supplements in the United States and worldwide. |
Company Summary more  NBTY, Inc. manufactures, markets, and retails nutritional supplements in the United States and worldwide. It offers various products, including vitamins, minerals, and sports and other nutritional supplements; food products, such as fruits, nuts, and confectionery products; and personal care products. The company markets approximately 25,000 products under the brands Nature's Bounty, Ester-C, Solgar, MET-Rx, American Health, Osteo Bi-Flex, Flex-A-Min, SISU, Knox, Sundown, Rexall, Pure Protein, Body Fortress, WORLDWIDE Sport Nutrition, Natural Wealth, Puritan's Pride, Holland & Barrett, GNC (UK), Physiologics, Le Naturiste, De Tuinen, Julian Graves, and Vitamin World. It primarily sells its p... NBTY, Inc. manufactures, markets, and retails nutritional supplements in the United States and worldwide. It offers various products, including vitamins, minerals, and sports and other nutritional supplements; food products, such as fruits, nuts, and confectionery products; and personal care products. The company markets approximately 25,000 products under the brands Nature's Bounty, Ester-C, Solgar, MET-Rx, American Health, Osteo Bi-Flex, Flex-A-Min, SISU, Knox, Sundown, Rexall, Pure Protein, Body Fortress, WORLDWIDE Sport Nutrition, Natural Wealth, Puritan's Pride, Holland & Barrett, GNC (UK), Physiologics, Le Naturiste, De Tuinen, Julian Graves, and Vitamin World. It primarily sells its products to mass merchandisers, club stores, drug store chains and supermarkets, wholesale clubs, independent pharmacies, health food stores, health food store wholesalers, the military and other retailers. The company also sells its products through mail order catalog and the Internet. As of September 30, 2009, it operated 442 Vitamin World stores in the United States; 86 Le Naturiste stores in Canada; 537 Holland and Barrett stores in Europe; 351 Julian Graves stores and 31 GNC (UK) stores in the United Kingdom; 80 De Tuinen stores in the Netherlands; 24 Nature's Way stores in Ireland; and 9 franchise Holland and Barrett stores in South Africa. The company was formerly known as Nature's Bounty, Inc. and changed its name to NBTY, Inc. in March 1995. NBTY, Inc. was founded in 1971 and is based in Ronkonkoma, New York. NBTY, Inc. manufactures, markets, and retails nutritional supplements in the United States and worldwide. It offers various products, including vitamins, minerals, and sports and other nutritional supplements; food products, such as fruits, nuts, and confectionery products; and personal care products. The company markets approximately 25,000 products under the brands Nature's Bounty, Ester-C, Solgar, MET-Rx, American Health, Osteo Bi-Flex, Flex-A-Min, SISU, Knox, Sundown, Rexall, Pure Protein, Body Fortress, WORLDWIDE Sport Nutrition, Natural Wealth, Puritan's Pride, Holland & Barrett, GNC (UK), Physiologics, Le Naturiste, De Tuinen, Julian Graves, and Vitamin World. It primarily sells its p... Top Stories| | 2010-09-01 |  | |
| | | 2010-09-01 |  | |
| | | 2010-08-31 |  | |
| | |
Earnings Postmortem for NBTY; NTY, PRGO, SLXP, HLF
Learning Markets - Aug 31, 2010
NBTY, Inc. (NTY) [Chart - Analysis - News] released its most recent earnings statement about a month ago on Wednesday, July 28th. NBTY, Inc. beat expectations with a profit of $1.03 per share---21 ...
2010-08-31 |  | |
|
Community Discussions |